Jefferies downgraded Evotec to Hold from Buy with a price target of $3.80, down from $8.70. The firm expects Evotec’s strategic reset to take time, with “lingering uncertainty over when the market will recover.” A lack of clarity over the business trajectory in 2025 and beyond, plus risk of further delays to the strategy update, “could amplify concerns further,” the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVO:
- Evotec price target lowered to $8 from $11 at H.C. Wainwright
- Evotec AG Posts Modest Revenue Growth Amidst Cost Challenges
- Evotec price target lowered to EUR 4 from EUR 10 at Deutsche Bank
- Evotec downgraded to Sell from Hold at Deutsche Bank